by Brandon Tudor | Jun 19, 2025 | Uncategorized
From JAMA Internal Medicine, June 16, 2025: Adverse Liver Outcomes, Cardiovascular Events, and Mortality in Steatotic Liver Disease. Objective:To compare the risk of adverse liver outcomes, major cardiovascular events, and all-cause mortality among people with...
by Brandon Tudor | Jun 16, 2025 | Uncategorized
🏆 States on‑track to eliminate HCV by 2030 A 2020–17 model projected only three states—Connecticut, South Carolina, and Washington—are on pace to meet all WHO HCV elimination targets (diagnosis, treatment, incidence, mortality) by 2030 💊 Medicaid innovations &...
by Brandon Tudor | Jun 10, 2025 | Uncategorized
This superb site will tell you your state’s Hepatitis C grade. https://stateofhepc.org/From their website– “Hepatitis C: State of Medicaid Access is the culmination of work by the Center for Health Law and Policy Innovation of Harvard Law School...
by Brandon Tudor | Jun 7, 2025 | Uncategorized
Recent news from Barcelona: As a function of the very first Global Think Tank on Steatotic Liver Disease, supported by the Barcelona Institute for Global Health (ISGlobal) and held in the Palau Macaya of Barcelona on June 5-6, 2025, 100+ international experts issued a...
by Brandon Tudor | Jun 5, 2025 | Uncategorized
An article recently published in Diabetes Care highlights the significant interplay between metabolic dysfunction–associated steatotic liver disease (MASLD) and type 2 diabetes. Summary– 🔄 Bidirectional Relationship Between MASLD and T2D Prevalence:...
